Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam oral paste for pain in burning mouth syndrome
IRCT20120101008585N13Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of clonazepam in glossodynia (BMS) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Amount of pain. Started Apr 2022; status: completed.
02
Drugs
clonazepam
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on IRCT20120101008585N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120101008585N13.